MARVIN YARBROUGH: Open Payments
NPI 1285327452 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$129 in 7 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $38 · 2025 $129
Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: PAXLOVID, BREZTRI, REXULTI, CAPLYTA, TRELEGY ELLIPTA, JOURNAVX.
Industry payments across AR — which companies pay providers there.
